Bio-Techne Corporation functions as a vital supplier and technology partner to the global life sciences and pharmaceutical research communities. Their core activity is the manufacturing of a wide array of high-quality research tools—including proteins, antibodies, and immunoassay platforms—that allow scientists to investigate biological processes at the molecular level. Additionally, the company excels in the manufacturing of clinical diagnostic equipment and highly regulated reagents necessary for the development and commercial production of cell and gene therapies. By providing the essential infrastructure, analytical instruments, and biological materials required for research, Bio-Techne enables the entire discovery lifecycle, from the earliest stages of academic basic research to the complex, large-scale manufacturing of therapeutic products. In essence, they act as the technological bedrock upon which many of the modern breakthroughs in medicine, oncology, and regenerative biology are built.
Bio-Techne Corporation employs several thousand highly skilled professionals across its global operations, which include manufacturing sites, research facilities, and commercial sales offices.
Biotechnology is generally considered a high-paying field, particularly when compared to average national salary benchmarks in many developed nations.
Salaries in the biotechnology field are highly variable and depend on factors such as educational level, specific job function, geographic location, and company size.
Biotechnology and genetic engineering are closely related but represent different concepts in the scientific field.
Biotechnology encompasses a wide range of applications that improve human health and sustainability.
Bio-Techne Corporation is a publicly traded company, listed on the Nasdaq stock exchange under the ticker symbol TECH.
Finding a job in the biotechnology sector is challenging but highly achievable for candidates who possess the right combination of specialized education, practical laboratory skills, and persistent networking.
The timeline to become a professional in the biotechnology field varies by the specific role.
Bio-Techne Corporation, originally founded as Techne Corporation in 1976, has a history rooted in the evolution of modern molecular biology and the demand for high-quality research tools.
Bio-Techne operates in a highly competitive life sciences tools and clinical diagnostics market, facing rivalry from other global giants that also manufacture research reagents, proteins, and analytical instrumentation.
Bio-Techne is generally perceived as a strong, stable employer within the life sciences sector, known for offering a professional work environment, competitive compensation, and a clear alignment with the mission of advancing scientific discovery.
Bio-Techne generates revenue primarily through the manufacturing and sale of high-value life science research products and clinical diagnostics.
The biotechnology sector is well-known for offering highly competitive compensation packages, especially for roles that require specialized technical education, such as Ph.D. holders, molecular biologists, data scientists, and process engineers.
Bio-Techne provides an extensive and highly sophisticated catalog of research products that serve as foundational tools for life science laboratories worldwide.
Determining whether Bio-Techne (TECH) stock is a "good buy" depends entirely on your personal investment philosophy, your risk tolerance, and your analysis of the life sciences market.
Kim Kelderman serves as the Chief Executive Officer of Bio-Techne Corporation. Taking on this leadership role, he is responsible for overseeing the company's long-term strategic vision, global operations, and financial performance.
Biotech jobs can be highly competitive, particularly for top-tier research or specialized engineering roles at prestigious firms.
Biotechnology is broadly categorized into four primary sectors, represented by different colors: Red, Green, White, and Blue.
Minneapolis and the broader Twin Cities metropolitan area constitute a significant, internationally recognized hub for medical technology and biotechnology innovation.
Bio-Techne Corporation is headquartered in Minneapolis, Minnesota, in the United States. This central location serves as the hub for the company’s executive leadership, strategic operations, and financial administration.
Bio-Techne Corporation reports significant annual revenues reflecting its position as a global leader in life sciences tools and clinical diagnostics.
Comparing the difficulty of biotechnology and engineering is inherently subjective, as both fields are intellectually demanding but require different types of cognitive approaches.
The amount of math in biotechnology varies significantly depending on your role.
A career in biotechnology can be demanding and, at times, inherently stressful due to the high-stakes environment in which professionals operate.
No, biotech jobs are not broadly declining; in fact, the sector has demonstrated remarkable resilience and long-term secular growth driven by advances in medicine, aging global demographics, and the digital transformation of biological research.